Tulisokibart, a tumor necrosis factor-like cytokine 1A monoclonal antibody, is more effective in inducing clinical remission ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Monoclonal antibodies—treatments developed by cloning a cell that makes an antibody—could help provide an answer to the growing problem of antimicrobial resistance, say scientists. A team lead ...

The Madras High Court set aside the rejection of Kymab Limited's patent application, ruling that the invention for antibody ...

Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...

Candid Therapeutics Inc. launched with ex-China control of two bispecific T-cell engager antibodies that it plans to develop for autoimmune diseases. The San Diego-based company will start off with a ...

Antibodies provided by mpox vaccination all but disappear within six to 12 months, new research finds, underscoring the need ...

Immunity against mpox may be waning for those vaccinated with the modified vaccinia Ankara-Bavarian Nordic (MVA-BN; Jyn ...

Bispecific Antibodies Market size Expected to surpass USD 40 Biilion By 2029 Says Kuick ResearchDelhi, Oct. 04, 2024 (GLOBE ...